{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:03Z","timestamp":1772136483995,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007727","name":"Biodesign Institute, Arizona State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32690-8","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T03:33:04Z","timestamp":1766115184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement"],"prefix":"10.1038","volume":"16","author":[{"given":"Alexandra R.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henna","family":"Monder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junior","family":"Enow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheyanne","family":"Woodrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Spaccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessika","family":"Schlievert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Elmadbouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashika","family":"Dupati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Aliskevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Saju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Kilbourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey","family":"Pinteric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela R.","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritvik Srivant","family":"Satyanarayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savanah","family":"Gisriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther Borges","family":"Florsheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masmudur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"32690_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart, D. C. & Carding, S. R. Inflammatory bowel disease: Cause and immunobiology. Lancet 369, 1627\u20131640 (2007).","journal-title":"Lancet"},{"key":"32690_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos, G. P. & Papadakis, K. A. Mechanisms of disease: Inflammatory bowel diseases. Mayo Clin. Proc. 94, 155\u2013165 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"32690_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000116773","volume":"26","author":"A Papa","year":"2008","unstructured":"Papa, A. et al. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis. 26, 149\u2013155 (2008).","journal-title":"Dig Dis."},{"key":"32690_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108176","volume":"238","author":"X Pan","year":"2022","unstructured":"Pan, X., Zhu, Q., Pan, L. L. & Sun, J. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy. Pharmacol. Ther. 238, 108176 (2022).","journal-title":"Pharmacol. Ther."},{"key":"32690_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.896591","volume":"10","author":"S Ma","year":"2022","unstructured":"Ma, S., Zhang, J., Liu, H., Li, S. & Wang, Q. The Role of tissue-resident macrophages in the development and treatment of inflammatory bowel disease. Front Cell Dev. Biol. 10, 896591 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"32690_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200281","volume":"9","author":"L Hong","year":"2022","unstructured":"Hong, L. et al. Balancing microthrombosis and inflammation via injectable protein hydrogel for inflammatory bowel disease. Adv Sci (Weinh) 9, e2200281. https:\/\/doi.org\/10.1002\/advs.202200281 (2022).","journal-title":"Adv Sci (Weinh)"},{"key":"32690_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307\u2013317 (2011).","journal-title":"Nature"},{"key":"32690_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-015-0044-2","author":"M Giannotta","year":"2015","unstructured":"Giannotta, M., Tapete, G., Emmi, G., Silvestri, E. & Milla, M. Thrombosis in inflammatory bowel diseases: What\u2019s the link?. Thromb. J. https:\/\/doi.org\/10.1186\/s12959-015-0044-2 (2015).","journal-title":"Thromb. J."},{"key":"32690_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3748\/wjg.v20.i1.53","volume":"20","author":"D Owczarek","year":"2014","unstructured":"Owczarek, D., Cibor, D., G\u0142owacki, M. K., Rodacki, T. & Mach, T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J. Gastroenterol. 20, 53\u201363 (2014).","journal-title":"World J. Gastroenterol."},{"key":"32690_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103758","volume":"75","author":"Y Cheng","year":"2022","unstructured":"Cheng, Y. et al. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease. EBioMedicine 75, 103758. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103758 (2022).","journal-title":"EBioMedicine"},{"key":"32690_CR11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1023\/A:1023793502456","volume":"48","author":"L Bene","year":"2003","unstructured":"Bene, L. et al. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn\u2019s disease than ulcerative colitis. Dig. Dis. Sci. 48, 1186\u20131192 (2003).","journal-title":"Dig. Dis. Sci."},{"key":"32690_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2249.2010.04093.x","volume":"160","author":"T Sugihara","year":"2010","unstructured":"Sugihara, T. et al. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin. Exp. Immunol. 160, 386\u2013393 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"32690_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1136\/gutjnl-2023-329689","volume":"72","author":"M Akhlaghpour","year":"2023","unstructured":"Akhlaghpour, M. et al. International IBD Genetics Consortium; Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn\u2019s disease and leads to impaired CFB cleavage and phagocytosis. Gut 72, 2068\u20132080 (2023).","journal-title":"Gut"},{"key":"32690_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3164\/jcbn.12-63","volume":"52","author":"T Aomatsu","year":"2013","unstructured":"Aomatsu, T. et al. Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice. J Clin Biochem Nutr. 52, 72\u201375 (2013).","journal-title":"J Clin Biochem Nutr."},{"key":"32690_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1152\/ajpgi.90460.2008","volume":"295","author":"F Lu","year":"2008","unstructured":"Lu, F. et al. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 295, 1042\u20131049 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"32690_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/mi.2015.18","volume":"8","author":"C Ning","year":"2015","unstructured":"Ning, C. et al. Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1\u03b2\/IL-17A axis. Mucosal. Immunol. 8, 1275\u20131284 (2015).","journal-title":"Mucosal. Immunol."},{"key":"32690_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217144","author":"MC Bouton","year":"2023","unstructured":"Bouton, M. C. et al. The under-appreciated world of the serpin family of serine protease inhibitors. EMBO Mol. Med. https:\/\/doi.org\/10.15252\/emmm.202217144 (2023).","journal-title":"EMBO Mol. Med."},{"key":"32690_CR18","doi-asserted-by":"publisher","first-page":"33293","DOI":"10.1074\/jbc.R100016200","volume":"276","author":"GA Silverman","year":"2001","unstructured":"Silverman, G. A. et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293\u201333296 (2001).","journal-title":"J. Biol. Chem."},{"key":"32690_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MEG.0b013e3282f246c2","volume":"20","author":"PM Irving","year":"2008","unstructured":"Irving, P. M. et al. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 20, 283\u2013289 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"32690_CR20","doi-asserted-by":"publisher","first-page":"e26144","DOI":"10.7759\/cureus.26144","volume":"14","author":"AK Dang","year":"2022","unstructured":"Dang, A. K. et al. Vinculum of cardiovascular disease and inflammatory bowel disease: A narrative review. Cureus. 14, e26144. https:\/\/doi.org\/10.7759\/cureus.26144 (2022).","journal-title":"Cureus."},{"key":"32690_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ibd\/izaa160","volume":"27","author":"M Pepe","year":"2021","unstructured":"Pepe, M. et al. Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. Inflamm. Bowel Dis. 27, 725\u2013731 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"32690_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1097\/MIB.0000000000000056","volume":"20","author":"U Jain","year":"2014","unstructured":"Jain, U., Otley, A. R., Van Limbergen, J. & Stadnyk, A. W. The complement system in inflammatory bowel disease. Inflamm. Bowel Dis. 20, 1628\u20131637 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"32690_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/MIB.0000000000000348","volume":"21","author":"JB Seidelin","year":"2015","unstructured":"Seidelin, J. B., Kvist, P. H., Bjerrum, J. T., Soendergaard, C. & Nielsen, O. H. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis. Inflamm. Bowel Dis. 21, 1077\u20131088 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"32690_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/ecco-jcc\/jjad160","volume":"18","author":"B J\u00f3j\u00e1rt","year":"2024","unstructured":"J\u00f3j\u00e1rt, B. et al. Plasminogen Activator Inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases. J Crohn\u2019s Colitis. 18, 392\u2013405 (2024).","journal-title":"J Crohn\u2019s Colitis."},{"key":"32690_CR25","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMra1907607","volume":"385","author":"DC Baumgart","year":"2021","unstructured":"Baumgart, D. C. & Le Berre, C. Newer biologic and small-molecule therapies for inflammatory bowel disease. N Engl. J. Med. 385, 1302\u20131315 (2021).","journal-title":"N Engl. J. Med."},{"key":"32690_CR26","doi-asserted-by":"publisher","first-page":"0852","DOI":"10.1126\/scitranslmed.aat0852","volume":"11","author":"GE Kaiko","year":"2019","unstructured":"Kaiko, G. E. et al. PAI-1 augments mucosal damage in colitis. Sci. Transl. Med. 11, 0852. https:\/\/doi.org\/10.1126\/scitranslmed.aat0852 (2019).","journal-title":"Sci. Transl. Med."},{"key":"32690_CR27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1097\/MIB.0b013e3182802c6a","volume":"19","author":"CB Collins","year":"2013","unstructured":"Collins, C. B. et al. Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm. Bowel Dis. 19, 1964\u20131973 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"32690_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MIB.0000000000000308","volume":"21","author":"S Matalon","year":"2015","unstructured":"Matalon, S. et al. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis. Inflamm. Bowel Dis. 21, 589\u2013595 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"32690_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","volume":"18","author":"PA Olivera","year":"2021","unstructured":"Olivera, P. A. et al. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 18, 857\u2013873 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"32690_CR30","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.3748\/wjg.v11.i32.4997","volume":"11","author":"SM Maksan","year":"2005","unstructured":"Maksan, S. M., \u00dclger, Z., Gebhard, M. M. & Schmidt, J. Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis. World J Gastroenterol. 11, 4997\u20135001 (2005).","journal-title":"World J Gastroenterol."},{"key":"32690_CR31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","volume":"211","author":"Z Kaner","year":"2015","unstructured":"Kaner, Z. et al. Acute phase protein \u03b11-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses. J. Infect. Dis. 211, 1489\u20131498 (2015).","journal-title":"J. Infect. Dis."},{"key":"32690_CR32","doi-asserted-by":"publisher","first-page":"G1163","DOI":"10.1152\/ajpgi.00292.2011","volume":"302","author":"K Uchiyama","year":"2012","unstructured":"Uchiyama, K. et al. Serpin B1 protects colonic epithelial cell via blockage of neutrophil elastase activity and its expression is enhanced in patients with ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1163\u2013G1170 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"32690_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jcmgh.2021.04.004","volume":"12","author":"YT Ho","year":"2021","unstructured":"Ho, Y. T. et al. Longitudinal single-cell transcriptomics reveals a role for Serpina3n-mediated resolution of inflammation in a mouse colitis model. Cell Mol. Gastroenterol. Hepatol. 12, 547\u2013566 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"32690_CR34","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1007\/s10620-011-1630-1","volume":"56","author":"JP Im","year":"2011","unstructured":"Im, J. P. et al. Rectal administration of lipopolysaccharide and ovalbumin ameliorates acute murine colitis. Dig Dis Sci. 56, 2292\u20132298 (2011).","journal-title":"Dig Dis Sci."},{"key":"32690_CR35","doi-asserted-by":"publisher","first-page":"e0023224","DOI":"10.1128\/iai.00232-24","volume":"92","author":"X Li","year":"2024","unstructured":"Li, X. et al. Echinococcus multilocularis serpin regulates macrophage polarization and reduces gut dysbiosis in colitis. Infect. Immun. 92, e0023224. https:\/\/doi.org\/10.1128\/iai.00232-24 (2024).","journal-title":"Infect. Immun."},{"key":"32690_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/viro.1993.1385","volume":"195","author":"JL Macen","year":"1993","unstructured":"Macen, J. L., Upton, C., Nation, N. & McFadden, G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology 195, 348\u2013363 (1993).","journal-title":"Virology"},{"key":"32690_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4615-5391-5_19","volume":"425","author":"P Nash","year":"1997","unstructured":"Nash, P., Lucas, A. & McFadden, G. SERP-1, a Poxvirus-encoded Serpin, is expressed as a secreted glycoprotein that inhibits the inflammatory response to myxoma virus infection. Adv. Exp. Med. Biol. 425, 195\u2013205 (1997).","journal-title":"Adv. Exp. Med. Biol."},{"key":"32690_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0021-9258(18)54181-8","volume":"268","author":"DA Lomas","year":"1993","unstructured":"Lomas, D. A., Evans, D. L., Upton, C., McFadden, G. & Carrell, R. W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J. Biol. Chem. 268, 516\u2013521 (1993).","journal-title":"J. Biol. Chem."},{"key":"32690_CR39","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1161\/01.CIR.94.11.2890","volume":"94","author":"A Lucas","year":"1996","unstructured":"Lucas, A. et al. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation 94, 2890\u20132900 (1996).","journal-title":"Circulation"},{"key":"32690_CR40","doi-asserted-by":"publisher","first-page":"18563","DOI":"10.1074\/jbc.M209683200","volume":"278","author":"E Dai","year":"2003","unstructured":"Dai, E. et al. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury. J. Biol. Chem. 278, 18563\u201318572 (2003).","journal-title":"J. Biol. Chem."},{"key":"32690_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1189\/jlb.0808506","volume":"85","author":"K Viswanathan","year":"2009","unstructured":"Viswanathan, K. et al. Myxoma viral serpin, Serp-1, inhibits human monocyte activation through regulation of actin binding protein filamin B. J. Leukoc. Biol. 85, 418\u2013426 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"32690_CR42","doi-asserted-by":"publisher","first-page":"633212","DOI":"10.3389\/fcvm.2021.633212","volume":"8","author":"Q Guo","year":"2021","unstructured":"Guo, Q. et al. PEGylated Serp-1 markedly reduces pristane-induced experimental diffuse alveolar hemorrhage, altering uPAR distribution and macrophage invasion. Front. Cardiovasc. Med. 8, 633212. https:\/\/doi.org\/10.3389\/fcvm.2021.633212 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"32690_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317376","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Treatment with anti-inflammatory viral serpin modulates immuno-thrombotic responses and improves outcomes in SARS-CoV-2 infected mice. EMBO Mol. Med. https:\/\/doi.org\/10.15252\/emmm.202317376 (2023).","journal-title":"EMBO Mol. Med."},{"key":"32690_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/CIRCINTERVENTIONS.110.953885","volume":"3","author":"J-C Tardif","year":"2010","unstructured":"Tardif, J.-C. et al. A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ. Cardiovasc. Interv. 3, 543\u2013548 (2010).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"32690_CR45","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","volume":"23","author":"DD Eichele","year":"2017","unstructured":"Eichele, D. D. & Kharbanda, K. K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J. Gastroenterol. 23, 6016\u20136029 (2017).","journal-title":"World J. Gastroenterol."},{"key":"32690_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1152\/ajpgi.00467.2004","volume":"288","author":"S Melgar","year":"2005","unstructured":"Melgar, S., Karlsson, A. & Micha\u00eblsson, E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: Correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288, 51\u201360 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"32690_CR47","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/jcm8101626","volume":"8","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. A virus-derived immune modulating serpin accelerates wound closure with improved collagen remodeling. J. Clin. Med. 8, 1626\u20131643. https:\/\/doi.org\/10.3390\/jcm8101626 (2019).","journal-title":"J. Clin. Med."},{"key":"32690_CR48","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1160\/TH09-07-0441","volume":"103","author":"G Munuswamy-Ramanujam","year":"2010","unstructured":"Munuswamy-Ramanujam, G. et al. Serpins targeting thrombolytic proteases alter T helper lymphocyte sub population. Neuroserpin, a thrombolytic serine protease inhibitor (Serpin), blocks transplant vasculopathy with associated potent anti-inflammatory and anti-atherogenic activity in mouse aortic allograft transplant models. Thromb. Haemost. 103, 545\u2013555 (2010).","journal-title":"Thromb. Haemost."},{"key":"32690_CR49","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1128\/AAC.02594-12","volume":"57","author":"H Chen","year":"2013","unstructured":"Chen, H. et al. Myxomavirus serpin modulates protease pathways and prolongs survival in lethal herpesviral infection. Antimicrob. Agents Chemother. 57, 4114\u20134127 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"32690_CR50","doi-asserted-by":"publisher","first-page":"8041","DOI":"10.1074\/jbc.M509454200","volume":"281","author":"E Dai","year":"2006","unstructured":"Dai, E. et al. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses. J. Biol. Chem. 281, 8041\u20138050 (2006).","journal-title":"J. Biol. Chem."},{"key":"32690_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/ecco-jcc\/jjad160","volume":"18","author":"B J\u00f3j\u00e1rt","year":"2024","unstructured":"J\u00f3j\u00e1rt, B. et al. Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases. J. Crohn\u2019s Colitis 18, 392\u2013405 (2024).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"32690_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ibd\/izad140","volume":"30","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. LAMB3 promotes intestinal inflammation through SERPINA3 and is directly transcriptionally regulated by P65 in inflammatory bowel disease. Inflamm. Bowel Dis. 30, 257\u2013272 (2024).","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32690-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32690-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32690-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:06:59Z","timestamp":1769220419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32690-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32690"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32690-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7239271\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Alexandra Lucas is the founding scientist for Serpass Biologics, Inc. Serpass Biologics has provided no funding for this research. There is no conflict for any of the other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2767"}}